Physician profile
David E Zuech
NPI 1861499071
$4,338.12
in general payments reported to CMS, 2019-2025
17 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,208 · 2020: $94.69 · 2021: $251 · 2022: $133 · 2023: $151 · 2024: $172 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $2,910.33 | 2019-2020 | |
| Alcon Vision LLC | $648.14 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Shire North American Group INC | $155.74 | 2019 | |
| Allergan, INC. | $145.04 | 2020-2022 | |
| Glaukos Corporation | $97.62 | 2019-2025 | Idosetr |
| Astellas Pharma US INC | $76.04 | 2024-2025 | Izervay |
| Ocular Therapeutix, INC. | $59.60 | 2021-2023 | Dextenza |
| Abbvie INC. | $49.31 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $48.57 | 2024-2025 | Xdemvy |
| The Cameron-Ehlen Group, INC. | $26.96 | 2019 | |
| Horizon Therapeutics Plc | $25.46 | 2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $21.89 | 2021 | |
| Merz North America, INC. | $18.74 | 2020 | |
| Harrow Eye, LLC | $18.53 | 2025 | Triesence |
| Rayner Intraocular Lenses Limited | $13.90 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $11.61 | 2020 | |
| Katena Products, INC. (Dba Corza Medical) | $10.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zuech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.